Conference
PCN128 The Cost-Effectiveness of 2nd Line Crizotinib in EML4-Alk Rearranged Advanced NSCLC in Ontario
Authors
Djalalov S; Graham DM; Beca J; Hoch JS; Tsao MS; Cutz JC; Leighl N
Volume
17
Publisher
Elsevier
Publication Date
May 2014
DOI
10.1016/j.jval.2014.03.523
Conference proceedings
Value in Health
Issue
3
ISSN
1098-3015